NuVasive Raises 2013 Revenue Guidance Above Street View

(RTTNews) - NuVasive, Inc. (NUVA), a medical company focused on developing minimally disruptive surgical products and procedures for the spine, Wednesday said it has raised its guidance for 2013 revenue to approximately $683 million from the previously projected $670 million. Analysts estimate revenue for the year to be $670.65 million. The company announced that it expects fourth-quarter revenue of approximately $189 million; 14 percent higher than the corresponding period of last year.

In addition, NuVasive now expects full-year 2013 operating margin, excluding items, to exceed previously issued guidance of approximately 14.5 percent. The company also said it expects 2014 revenue of $725 million, which matches with the mid-single digit revenue growth guidance previously announced.

The company said, "As we embark on 2014, we remain laser focused on our company-wide mission to change spine surgery with Speed of Innovation, Absolute Responsiveness, and a commitment to improved spine patient outcomes."

NuVasive will report fourth quarter and full year results after the market closed on March 3, 2014.